🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 74838K405
- Market Cap
- Mid Cap · $593 Million
- IPO
- 10/26/2013 · $7.25/share
Business: Sorrento Therapeutics, Inc. is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn malignant cancers into manageable and possibly curable diseases. Sorrento's multimodal multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as fully human antibodies clinical stage immuno-cellular therapies intracellular targeting antibodies, antibody-drug conjugates and clinical stage oncolytic virus.
Company Contact
- CEO
- Henry Ji
- CFO
- Najjam Asghar
- Headquarters
- 4955 Directors Place, San Diego, CA 92121
- Phone
- 858-210-4100
- Fax
- 858-210-3759
- Investor Relations
- Alexis Nahama · 858-203-4120 · info@sorrentotherapeutics.com